Boston Scientific Soars 3.69% in Six Days, Driven by Strong Earnings and Moody's Upgrade

Boston Scientific (BSX) rose 0.58% today, marking its sixth consecutive day of gains, with a total increase of 3.69% over the past six days. The share price reached its highest level since February 2025, despite an intraday decline.

The strategy of buying Boston Scientific (NYSE:BSX) shares after they reached a recent high and holding for 1 week yielded moderate returns over the past five years. The 5-year annualized return was 21.8%, with a total return of 157.4%. While the strategy capitalized on the initial momentum, the lack of correlation between EPS changes and share price appreciation suggests that revenue growth might be a more significant factor. The compound annual growth rate (CAGR) of revenues over the 5 years was approximately 9.9%, which aligns with the total shareholder return (TSR) of 40% over the last 12 months, indicating a recent improvement in sentiment and stock performance.

Moody's recent upgrade of Boston Scientific's rating to A3 reflects the agency's expectation of sustained strong operating performance and revenue growth. This upgrade is likely to boost investor confidence, contributing to the positive sentiment surrounding the stock.

Boston Scientific has demonstrated impressive financial performance, with earnings per share (EPS) growing by 37% annually over the past three years. Additionally, the company's revenue increased by 19% to $18 billion, highlighting its robust growth trajectory and serving as a key driver for the stock's appreciation.

The company's strategic initiatives, such as its plan to invest $150 million to expand operations in China, indicate a focus on international growth. This expansion is likely viewed favorably by investors, as it signals the company's commitment to diversifying its revenue streams and tapping into new markets.

Boston Scientific's strong market performance is further evidenced by its shares rising by 19% since January, overtaking Thermo Fisher as the top company in Massachusetts. This achievement underscores the company's competitive edge and positive investor sentiment, contributing to its overall market position.